BCDA
BCDA
NASDAQ · Biotechnology

Biocardia Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$1.11
+0.02 (+1.83%)
As of May 16, 2:29 AM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 7 88%
Hold 1 13%
Sell 0 0%
Price Target
Analyst Price Target +2,959.5% upside
Low Target $19.62
Average Target $33.96
High Target $35.69
Current Price $1.11
Current
$1.11
Target
$33.96
$19.62 $33.96 avg $35.69
Scenario Analysis
Bear Case
$19.62
1,667.6%
Low target
Base Case
$33.96
+2,959.5%
Avg target
Bull Case
$35.69
+3,115.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$2.92
-62.0% from high
52-Week Low
$1.00
+11.0% from low
Target vs 52W High
$33.96
+1,063.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%